Amneal Pharmaceuticals taps GLP-1 growth via a Pfizer-linked manufacturing deal, gaining exposure without clinical risks while scaling injectables and peptides.
Rs 2.38 lakh crore defence approvals create a multi-year pipeline, led by Rs 65,000 crore helicopters and Rs 30,000 crore ...
Partnership is designed to pair EDERRA’s farm-to-body functional nutrition thesis with Cepham’s evidence-based manufacturing capabilities and supply-chain rigor ...
Santa Monica begins $56 million zero-emission bus fleet expansion with 73 electric buses and charging infrastructure, funded ...
Following its Public Listing in the First Quarter of 2026, Xanadu Entered 2026 with Strengthened Capital Resources to Execute Against a ...
India’s railway boom is evident. But the next phase of value creation may not be. A set of companies is emerging that profits ...
H55, a Swiss-based leader in certified electric propulsion and energy storage systems for aviation, has delivered conforming ...
Introduction: The upcoming ten years of innovation will establish their identity through the implementation of technological ...
Quanta Services, Inc. PWR has entered a new phase of long-term visibility, underpinned by a record backlog of approximately $44 billion. Management emphasized that this backlog is broad-based across ...
Following its Public Listing in the First Quarter of 2026, Xanadu Entered 2026 with Strengthened Capital Resources to Execute Against a Multi-Year Technology Roadmap Spanning Fault Tolerance, Manufact ...
The contrast between the 787 and A350 highlights a broader tension in engineering: the balance between innovation and ...
(Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results